Literature DB >> 9265919

Switching antipsychotic medications.

P J Weiden1, R Aquila, L Dalheim, J M Standard.   

Abstract

Compared with conventional antipsychotics, the so-called "atypical" antipsychotics promise improved side effect profiles and better control of the symptoms of schizophrenia. Therefore, most patients currently taking conventional antipsychotics could potentially benefit from a switch to an atypical antipsychotic. Often, the key issue in deciding whether to switch is the presence of countervailing factors that mitigate against the change. This paper discusses the indications and contraindications for switching antipsychotics, plus issues that require consideration before a switch is made. Also, the advantages and disadvantages of various switching techniques are discussed, with a particular focus on the newer antipsychotic olanzapine.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9265919

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  11 in total

Review 1.  Switching between second-generation antipsychotics: why and how?

Authors:  Monika Edlinger; Susanne Baumgartner; Nadja Eltanaihi-Furtmüller; Martina Hummer; W Wolfgang Fleischhacker
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 2.  Immediate vs Gradual Discontinuation in Antipsychotic Switching: A Systematic Review and Meta-analysis.

Authors:  Hiroyoshi Takeuchi; Navot Kantor; Hiroyuki Uchida; Takefumi Suzuki; Gary Remington
Journal:  Schizophr Bull       Date:  2017-07-01       Impact factor: 9.306

3.  Pragmatic replication trial of health promotion coaching for obesity in serious mental illness and maintenance of outcomes.

Authors:  Stephen J Bartels; Sarah I Pratt; Kelly A Aschbrenner; Laura K Barre; John A Naslund; Rosemarie Wolfe; Haiyi Xie; Gregory J McHugo; Daniel E Jimenez; Ken Jue; James Feldman; Bruce L Bird
Journal:  Am J Psychiatry       Date:  2014-12-12       Impact factor: 18.112

Review 4.  Impact of atypical antipsychotics on quality of life in patients with schizophrenia.

Authors:  A George Awad; Lakshmi N P Voruganti
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 5.  Selective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria.

Authors:  K Black; C Shea; S Dursun; S Kutcher
Journal:  J Psychiatry Neurosci       Date:  2000-05       Impact factor: 6.186

6.  Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine.

Authors:  Miho Tada; Kiyoharu Shirakawa; Nobuya Matsuoka; Seitaro Mutoh
Journal:  Psychopharmacology (Berl)       Date:  2004-04-09       Impact factor: 4.530

7.  Effectiveness of lurasidone in schizophrenia or schizoaffective patients switched from other antipsychotics: a 6-month, open-label, extension study.

Authors:  Leslie Citrome; Peter J Weiden; Joseph P McEvoy; Christoph U Correll; Josephine Cucchiaro; Jay Hsu; Antony Loebel
Journal:  CNS Spectr       Date:  2013-12-16       Impact factor: 3.790

8.  Prescribing practices of clozapine in India: Results of a opinion survey of psychiatrists.

Authors:  Amresh Shrivastava; Nilesh Shah
Journal:  Indian J Psychiatry       Date:  2009 Jul-Sep       Impact factor: 1.759

9.  Commentary on strategies for switching antipsychotics.

Authors:  John M Davis; Stefan Leucht
Journal:  BMC Med       Date:  2008-06-30       Impact factor: 8.775

10.  Dosing and switching of paliperidone ER in patients with schizophrenia: recommendations for clinical practice.

Authors:  Joseph Peuskens; Gabriel Rubio; Andreas Schreiner
Journal:  Ann Gen Psychiatry       Date:  2014-04-01       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.